Fiche publication
Date publication
novembre 2025
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine
Tous les auteurs :
Antoni D, Mesny E, El Kabbaj O, Josset S, Quintin K, Boue-Rafle A, Tallet-Richard A, Latorzeff I
Lien Pubmed
Résumé
We present the updated recommendations of the Société française de radiothérapie oncologique (the French Society for Radiation Oncology) on the indications and technical modalities of radiotherapy for brain metastases. The management of brain metastases represents a complex therapeutic challenge, due to the increase in patient life expectancy, technological advances in imaging and radiotherapy, specific and relevant prognostic classifications, the increased intracranial efficacy of certain systemic therapies and also the possible iterative irradiation sequences. The prevention of acute and late side effects is essential. Therapeutic strategies defined in a multidisciplinary manner are becoming increasingly personalized and must be rediscussed according to the evolution of the intracranial and extracranial disease.
Mots clés
Brain metastasis, Cognition, Guidelines, Métastases cérébrales, Prognostic scores, Radiothérapie en conditions stéréotaxiques, Recommandations, SFRO, Scores pronostiques, Société française de radiothérapie oncologique, Stereotactic radiotherapy
Référence
Cancer Radiother. 2025 11 7;29(7-8):104765
